Celebrex · DIN 02239941 · 100 mg · capsule
Limited Use, Reason for Use code 316, 317 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 316, 317 required
Write on scriptone applicable Reason for Use code, 316 or 317 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 316, 317
Coverage limit:
Osteoarthritis
Reason for Use code 316
For patients who have failed an adequate trial of acetaminophen (e.g. acetaminophen 1g QID for several weeks) and have had:
Coverage limit:
History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS.
Coverage limit:
The maximum daily dose of celecoxib which will be reimbursed for the treatment of osteoarthritis is 200mg.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
Rheumatoid arthritis
Reason for Use code 317
For patients who have had:
Coverage limit:
History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS.
Coverage limit:
The maximum daily dose of celecoxib which will be reimbursed for the treatment of rheumatoid arthritis is 400mg.
Coverage limit:
LU Authorization Period: 1 year
Savings card: RxHelp ONE lists Celebrex (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Celebrex · DIN 02239941
Manufacturer: Upjohn Canada ULC; listing date 2000-04-17
Health Canada: Marketed since 2023-09-26 · brand CELEBREX · ATC M01AH01 CELECOXIB · form Capsule · route Oral · ingredients CELECOXIB 100 MG · company Bgp pharma ulc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02239941)
Source record
DIN 02239941: Celebrex
Raw flags: sec12=Y, sec3=Y
Item: 280804075; group id 377; item number 0898; lccId 00064; manufacturer id UJC
Source form: Cap; strength: 100mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.8482; ministry $0.1279
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02239941
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63442
Therapeutic Notes (formulary)
NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.
Interchangeable products
AG-Celecoxib · DIN 02437570 · $0.1279
Act Celecoxib · DIN 02420155 · $0.1279
Apo-Celecoxib · DIN 02418932 · $0.1279
Auro-Celecoxib · DIN 02445670 · $0.1279
Bio-Celecoxib · DIN 02426382 · $0.1279
Celecoxib · DIN 02429675 · $0.1279
Celecoxib · DIN 02436299 · $0.1279
Jamp-Celecoxib · DIN 02424533 · $0.1279
M-Celecoxib · DIN 02495465 · $0.1279
Mar-Celecoxib · DIN 02420058 · $0.1279
Mint-Celecoxib · DIN 02412497 · $0.1279
NRA-Celecoxib · DIN 02479737 · $0.1279
PMS-Celecoxib · DIN 02355442 · $0.1279
PMSC-Celecoxib · DIN 02517116 · $0.1279
Ran-Celecoxib · DIN 02412373 · $0.1279
Sdz Celecoxib · DIN 02442639 · $0.1279
Teva-Celecoxib · DIN 02288915 · $0.1279
Shortage status: not checked (no credentials)